mefenamic acid has been researched along with Headache in 4 studies
Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mefenamic acid is a non‑steroidal anti‑inflammatory drug exhibiting a wide range of anti‑inflammatory, antipyretic, analgesic and probable antiviral activities." | 3.11 | Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial. ( Beas-Guzman, O; Cardenas-Aguilar, CB; Chaviano-Conesa, D; Cuevas-Velazquez, AC; Delgado-Enciso, I; Delgado-Enciso, J; Delgado-Enciso, OG; Galvan-Salazar, HR; Garcia-Garcia, HS; Guzman-Esquivel, J; Guzman-Solorzano, HP; Guzman-Solorzano, JA; Martinez-Fierro, ML; Melnikov, V; Mokay-Ramirez, KA; Murillo-Zamora, E; Paz-Michel, BA; Rodriguez-Sanchez, IP; Rojas-Larios, F; Walle-Guillen, M, 2022) |
| " We suggest that the immune complex mechanism could have induced these adverse reactions." | 1.29 | Serious adverse effects induced by simultaneous administration of two nonsteroidal anti-inflammatory drugs. ( Awaya, N; Handa, M; Matsuyama, M; Ogino, M; Okada, H; Saruta, T; Suzuki, H; Toya, S, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guzman-Esquivel, J | 1 |
| Galvan-Salazar, HR | 1 |
| Guzman-Solorzano, HP | 1 |
| Cuevas-Velazquez, AC | 1 |
| Guzman-Solorzano, JA | 1 |
| Mokay-Ramirez, KA | 1 |
| Paz-Michel, BA | 1 |
| Murillo-Zamora, E | 1 |
| Delgado-Enciso, J | 1 |
| Melnikov, V | 1 |
| Delgado-Enciso, OG | 1 |
| Rodriguez-Sanchez, IP | 1 |
| Martinez-Fierro, ML | 1 |
| Rojas-Larios, F | 1 |
| Walle-Guillen, M | 1 |
| Cardenas-Aguilar, CB | 1 |
| Beas-Guzman, O | 1 |
| Chaviano-Conesa, D | 1 |
| Garcia-Garcia, HS | 1 |
| Delgado-Enciso, I | 1 |
| Okada, H | 1 |
| Suzuki, H | 1 |
| Awaya, N | 1 |
| Handa, M | 1 |
| Ogino, M | 1 |
| Matsuyama, M | 1 |
| Toya, S | 1 |
| Saruta, T | 1 |
| Buchmann, E | 1 |
| Holmes, EL | 1 |
3 trials available for mefenamic acid and Headache
| Article | Year |
|---|---|
Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial.
Topics: Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Combined Modality Therap | 2022 |
Mefenamic acid compared with indomethacin and placebo in osteoarthritis.
Topics: Anti-Inflammatory Agents; Clinical Trials as Topic; Diarrhea; Digestion; Duodenal Ulcer; Female; Fol | 1966 |
Experimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects.
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Biphenyl Compounds; Blood Coagulation; Blood Urea Nitrogen | 1966 |
1 other study available for mefenamic acid and Headache
| Article | Year |
|---|---|
Serious adverse effects induced by simultaneous administration of two nonsteroidal anti-inflammatory drugs.
Topics: Acute Kidney Injury; Agranulocytosis; Anemia, Hemolytic; Diclofenac; Drug Therapy, Combination; Fema | 1993 |